Family Group – Page 2

UCB’s Strategic Shift: Bristol Myers ADC Partner’s CEO Takes the Helm

12 months ago talkbio0Tagged Administration occupational activities, CEO, Changing, Drug Industry, Myers, Partner in relationship, strategic shift, therapeutic autologous dendritic cells, UCB

UCB, management changes, CEO, Bristol Myers, ADC partner, strategic shift, pharmaceutical industry.

Bristol Myers and Cellares Collaborate on Global CAR-T Manufacturing Deal

12 months ago talkbio0Tagged Biopharma, CAR-T, Cellares, diversification, Generalized, Manufacture, Myers, Partner in relationship

Bristol Myers, Cellares, CAR-T, biopharma, manufacturing partners, diversification, global deal

Boundless Bio, Oncology Startup Targeting Extrachromosomal DNA, Files for $100 Million IPO

1 year ago talkbio0Tagged Arch of foot, Backed, Bayer, bleomycin/dacarbazine/lomustine/vincristine, Boundless, Checkpoint Kinase 1 Inhibitors, extrachromosomal DNA, IPO, Nasdaq Listing, Oncology Startup, Partner in relationship, Phase 1 Trials, Preliminary, Public Offering, Second Half of 2024, small molecule drugs, symbol

Boundless Bio, Oncology Startup, Initial Public Offering (IPO), Extrachromosomal DNA (ecDNA), Small Molecule Drugs (ecDTx), Checkpoint Kinase 1 Inhibitors, Phase 1 Trials, Nasdaq Listing (Symbol: BOLD), Backed by Bayer and Arch Venture Partners, Preliminary Data Expected in Second Half of 2024

Forta Healthcare: $55M Series A to Scale AI-Driven Parent-Led Autism Therapy and Expand Services

1 year ago talkbio0Tagged Applied Behavior Analysis, Child, Forta

Forta, Child, Applied Behavior Analysis